Tramadol versus paracetamol versus placebo for pain relief and labor length in first-time mothers
Official title: Analgesic Efficacy and Obstetric Effects of Tramadol, Paracetamol and Placebo in Active Labor: A Randomized Double-Blind Controlled Trial
Run by Universidad Nacional Autonoma de Honduras · NCT07440069 · Data updated 2026-11-12
This trial will try IV tramadol, IV paracetamol, or saline to see which gives better pain relief and changes active labor length for first-time mothers in active labor.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 15 Years to 45 Years |
| Sex | Women only |
| Enrollment | 300 (estimated) |
| Sponsor | Universidad Nacional Autonoma de Honduras Academic / other |
| Locations | 2 sites (Tegucigalpa, Francisco Morazán Department and 1 other locations) |
| Status | Recruiting |
| Started | February 15, 2026 |
| Main results expected | November 30, 2026 |
| Study ends | November 30, 2026 |
| Registry record updated | November 5, 2026 |
| Trial ID | NCT07440069 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are nulliparous pregnant women aged 15–45 with a singleton term cephalic pregnancy in active labor (cervical dilation ≥4 cm) who can give informed consent.
✕Probably not a fit
Women with high-risk pregnancies, recent analgesic use, prior uterine surgery, non-cephalic presentation, prolonged rupture of membranes, active infection/fever, or inability to consent are excluded and unlikely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a randomized, double-blind, placebo-controlled, three-arm trial enrolling 300 nulliparous women in active labor at two Tegucigalpa hospitals. Participants receive a single IV dose of tramadol 100 mg, paracetamol 1 g, or saline at onset of active labor (≥4 cm dilation) and are followed through delivery. The primary endpoint is duration of active labor from intervention to full dilation; secondary endpoints include expulsive phase length, delivery type, need for oxytocin, maternal adverse events, and neonatal outcomes such as Apgar scores and NICU admission. Allocation is concealed and blinded for participants, clinicians, and outcome assessors, with statistical comparisons planned between the three groups.
Why it matters
Potential benefit: If successful, the results could identify a safe, effective IV analgesic that shortens active labor and improves comfort for first-time mothers.
How similar studies have gone: Previous smaller trials and clinical experience suggest opioids like tramadol can reduce labor pain and sometimes shorten labor, while IV paracetamol has less consistent evidence for benefiting active labor.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Nulliparous pregnant women * Age between 15 and 45 years * Singleton pregnancy, term (37-41 weeks gestation) * Cephalic presentation * Active labor defined as cervical dilation ≥4 cm with regular contractions * Signed informed consent Exclusion Criteria: * Multiple gestation or high-risk pregnancy (preeclampsia, gestational diabetes, etc.) * Known allergy or contraindication to tramadol or paracetamol * Recent use (less than 6 hours) of any analgesic medication * Previous cesarean section or other uterine surgery * Active infection or fever at admission * Inability to provide informed consent due to mental or communication conditions * Non-cephalic presentation * Rupture of membranes \>18 hours without labor * Participation in another clinical trial within the last 3 months
Where it's running
-
Hospital Escuela
Tegucigalpa, Francisco Morazán Department, Honduras Recruiting -
Instituto Hondureño de Seguridad Social
Tegucigalpa, Francisco Morazán Department, Honduras Recruiting
Study contacts
- Study coordinator: Ricardo A. Gutierrez-Ramirez, MD, MSc
- Email: ricardo.gutierrez@unah.edu.hn
- Phone: +50497546940
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Dural Puncture Epidural (DPE) Technique in Labor Analgesia
This observational study at Ohio State tests whether the DPE method can reliably reveal CSF and improve epidural placement during labor without injecting medication.
-
Midwife-guided Birth Affirmation Cards for Primigravidas
This study tests whether midwife-guided birth affirmation cards can shorten labor, reduce pain, and improve feelings of control and support for first-time mothers.
-
Left-side versus lying on your back to shorten the active phase of labor
This trial tests whether staying on your left side instead of lying on your back shortens the active phase of labor for first-time mothers at term.
-
TENS for pain relief during active labor
This trial will try using a TENS device versus a sham to see if it lowers pain for first-time moms during the active phase of labor.
-
PIEB versus CEI for epidural labor pain relief
This trial will test whether programmed intermittent epidural boluses (PIEB) or a continuous epidural infusion (CEI), each combined with patient-controlled epidural analgesia (PCEA), works better for pain relief during labor in women having vaginal delivery.
-
Effects of Pilates ball and sacral massage on labor pain and satisfaction
This study is testing whether using a Pilates ball or sacral massage can help pregnant women manage labor pain and feel more satisfied during childbirth.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.